2023 Financial Interest Disclosure: Submit here
As a provider accredited by the Accreditation Council on Continuing Medical Education, ASCRS•ASOA must ensure balance, independence, objectivity, and scientific rigor in all its individually or jointly provided activities.
All individuals participating in an ASCRS CME activity must disclose any financial interest or relationship with a company that produces, markets, resells, or distributes ophthalmic products/devices/drugs or services discussed in an educational presentation or lack thereof. Financial interest can include such things as grants or research support, consultant, stockholder, member of speaker’s bureau, financial relationships held by spouse, etc.
The intent of this disclosure is to provide the Program Committee with information so they can design and implement a balanced, independent, and scientific educational activity. The Financial Interest Index within the activity’s Final Program provides information to attendees so they can make their own judgment regarding the interest or relationship and the materials presented.
Potential participants in ASCRS-provided CME programs, including coauthors/coproducers/co-instructors and faculty, must provide a complete listing of ALL financial relationships relevant to ophthalmology – not just those related to a specific talk – in the financial interest disclosure database. Any relevant relationship that occurred within the previous 24 months should be reported. Those who have no financial interests to disclose should indicate “none” in the database. Disclosure information will be kept on file and used for all CME-bearing activities in an October-September cycle.
Who must submit a financial interest disclosure? All program participants to include:
- ASCRS Instructors and all co-instructors
- ASOA Instructors and all co-instructors
- Authors and all co-authors
- Producers and all co-producers
- Session Moderators and Panelists
- Room Hosts
This system ensures our continued compliance with the ACCME's guidelines and ensures we continue to provide exceptional quality continuing education; we also believe this system will streamline the process for you, thus improving your overall experience as a participant in our meetings. We thank you in advance for your assistance.
A complete listing of relationships to disclose and their corresponding codes is listed below. Please review the descriptions carefully before continuing.
2023 Financial Interest Disclosure: Submit here
| Category | Code | Description |
|---|---|---|
| Consultant/Advisor | C | I receive consultants fees or paid advisory boards, speakers bureaus or fees for attending a meeting from an ineligible company or provide practice management/marketing services to ophthalmic practices. |
| Employee | E | I am a part-time or full-time employee or have an ownership interest of an ineligible company. |
| Research/Grant Support | R | My research is fully or partially funded by an ineligible company |
| Lecture Fees | L | My lecture fees (honoraria), travel fees or reimbursements when speaking at the invitation of an ineligible company have been paid or subsidized by an ineligible company. |
| Patent/Royalty | P | I earn a royalty or derive other financial gain from an ophthalmic product or service. |
| Equity Owner/Investor | O | I have an investment interest/equity ownership/stock options in a publicly traded ingeligible company or stock futures in a privately held ineligible company. |